AMPH vs CTVA · P/E 12, rev $732.0M vs P/E 42, rev $16.91B
Amphastar P (AMPH) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the AMPH and CTVA stock pages for the full models.
Not investment advice.